Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Luveris Market CAGR Analysis And Future Market Development
The historic period’s growth resulted from several developments: an increase in infertility incidence, a worldwide surge in IVF clinic establishments, heightened public consciousness about hormonal infertility interventions, the market presence of recombinant hormone preparations, and breakthroughs in reproductive endocrinology.
The expansion anticipated during the forecast period stems from several factors, including the trend of mothers delaying childbirth, greater financial commitments to fertility clinics, broader acceptance of tailored reproductive healthcare, the widening scope of fertility preservation offerings, and heightened interest in sophisticated hormonal treatments. Key developments shaping this period encompass a growing preference for hormone-driven fertility interventions, a surge in the utilization of assisted reproductive methods, an escalating need for individually customized fertility care plans, the proliferation of multi-hormone treatment approaches, and a strengthened emphasis on managing ovulation through controlled induction.
Download A Free Sample Report For Comprehensive Market Insights:
Luveris Market Growth Factors Supporting Long-Term Expansion
The growth of the luveris market moving forward is expected to be driven by rising infertility rates. Infertility rates measure the proportion of couples or individuals unable to conceive after a specific period of trying, typically defined as one year of unprotected intercourse. These increasing rates stem from factors like delayed childbearing, lifestyle choices, environmental pollutants, and underlying health conditions. Luveris (lutropin alfa) addresses infertility in women with low luteinizing hormone (LH) levels by stimulating ovulation and encouraging egg development in the ovaries. For example, in July 2023, the Human Fertilisation and Embryology Authority, a UK-based regulator of fertility treatment and research, reported that the number of patients undergoing in vitro fertilisation (IVF) at HFEA-licensed fertility centers rose to 52,400 in 2023, up from previous years, while donor insemination (DI) treatments led to approximately 820 births, an increase from earlier years. As a result, the luveris market will be propelled by these rising infertility rates.
Expanding healthcare infrastructure is anticipated to fuel the luveris market’s growth moving forward. Healthcare infrastructure encompasses hospitals, clinics, medical equipment, healthcare workers, and other organizational and physical structures, buildings, resources, and systems essential for delivering healthcare services. This infrastructure is expanding to address increasing demand for medical services, driven by growing populations, aging demographics, advancements in healthcare technology, and the need for improved accessibility and care quality. Such expansion positively impacts luveris by enhancing access to advanced fertility treatments and supporting the growth of specialized medical centers that employ innovative therapies for infertility. For instance, in May 2023, the Department of Health and Social Care, a UK-based government department, announced an investment of over $25.33 billion (£20 billion) in the New Hospital Programme, which aims to build 40 new hospitals in England by 2030. Consequently, the expanding healthcare infrastructure will drive luveris market growth.
Luveris Market Segments: Where Are The Largest Growth Opportunities?
The luveris market covered in this report is segmented –
1) By Formulation: Injectable Formulation (Intravenous), Pre-Filled Syringes
2) By Indication: Treatment Of Hypogonadotropic Hypogonadism, Ovulation Induction, Assisted Reproductive Technology
3) By Route of Administration: Subcutaneous Injection, Intramuscular Injection
4) By Patient Demographics: Adult Female Patients, Adult Male Patients, Couples Undergoing Fertility Treatments
5) By End User: Hospitals, Fertility Clinics, Specialty Pharmacies, Home Healthcare Providers
Luveris Market Industry Trends Shaping Future Revenue Growth
A significant trend shaping the luveris market involves the adoption of a strategic investment approach to drive the development and manufacturing of innovative medicines. Such investments are designed to fulfill long-term business goals, such as securing a competitive edge, increasing market presence, or improving operational efficiency. To illustrate, in April 2024, Merck KGaA, a science and technology firm headquartered in Germany, allocated $316 million (€300 million) to establish a new research facility at its international headquarters in Darmstadt, Germany. This state-of-the-art research center will concentrate on creating solutions for antibody production, mRNA applications, and other biotechnological manufacturing needs within Merck’s Life Science business segment. The facility will combine efforts on critical technologies, covering raw materials and processes for producing antibodies, recombinant proteins, and viral vectors. Moreover, it will advance work on cell culture media, pharmaceutical formulation and purification aids, digital reference materials, and the improvement of analytical chromatography—a technique used to separate, identify, and quantify chemical substances. Research along the mRNA value chain will also be undertaken at this new location.
Luveris Market Major Participants And Competitive Dynamics
Major companies operating in the luveris market are Merck KGaA
Access The Complete Luveris Market Report:
Luveris Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the luveris market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the luveris market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model